Evidence map›Paper›PMID 39316322›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2024

Carbapenem resistant Campylobacter jejuni bacteremia in a Bruton's X-linked agammaglobulinemia patient.

Ran Zhuo, Ramee L Younes, Kevin Ward, Shangxin Yang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Antimicrobial use onFrontiers in microbiology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ran ZhuoDepartment of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, University of California, 11633 San Vicente Blvd, Los Angeles, CA, 90049, USA.
Ramee L YounesDivision of Infectious Diseases, UCLA David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Kevin WardDepartment of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, University of California, 11633 San Vicente Blvd, Los Angeles, CA, 90049, USA.
Shangxin YangDepartment of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, University of California, 11633 San Vicente Blvd, Los Angeles, CA, 90049, USA. ShangxinYang@mednet.ucla.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunocompromised patients are prone to recurrent Campylobacter infections. We report a case of recurrent multi-drug resistant Campylobactor jejuni bloodstream infections in a Bruton's X-linked agammaglobulinemia patient with prolonged ertapenem treatment. The isolate from the fifth recurrence developed carbapenem resistance, which is associated with mutations in a porin gene porA, and promoter changes and duplication of chromosomal blaOXA-61 gene. Combination therapy using cefepime and doxycycline (later switched to moxifloxacin) cleared the infection.

Indexed as

AgammaglobulinemiaAnti-Bacterial AgentsBacteremiaCampylobacter InfectionsCampylobacter jejuniGenetic Diseases, X-LinkedAdultCarbapenemsDrug Resistance, Multiple, BacterialHumansMaleAnti-Bacterial AgentsCarbapenemsCampylobacter jejuniCarbapenem resistanceGene duplicationOXA-61Porin mutationRecurrent bloodstream infections

Identifiers

PMID39316322
PMCPMC11608308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.